This article was originally published in The Gray Sheet
Surgical cryoablation system will debut in July following recent 510(k) clearance received by strategic partner Endocare for treatment of cardiac arrhythmias in patients undergoing other cardiac procedures such as bypass surgery and valve replacement. The firm sees a $200 mil. market opportunity...
You may also be interested in...
CryoCath aims to place its Freezor cryoablation catheter in 300 centers by year-end, pending PMA approval of the supraventricular tachycardia treatment device
Delay to Moderna's Phase III plans adds to the biotech's rollercoaster ride, but its CEO insists it is still on track.
This week's Device Week podcast covers recent regulatory developments in Asia in the wake of COVID-19, and how regulators are adjusting to working under the pandemic. Having published two updates from our regular Asian Medtech Associations Reg Networking discussions this week, Medtech Insight speaks to Asia Regulatory Professional Association founder Jack Wong on Asian regulatory themes and South Korea's hosting of the next International Medical Device School.